Barclays Maintains Overweight on Sempra, Lowers Price Target to $90
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsPrice TargetHot
Barclays analyst Nicholas Campanella maintains Sempra (NYSE:SRE) with a Overweight and lowers the price target from $103 to $90.
Barclays analyst Nicholas Campanella maintains Sempra (NYSE:SRE) with a Overweight and lowers the price target from $103 to $90.